clinical trial · NCT07545265
SKB565 for Injection in Advanced Solid Tumors
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.·phase2·not yet recruiting·n = 180
Advanced Solid TumorsSKB565
brief summary
This is a phase I/II clinical study to evaluate the safety and efficacy of SKB565 in participants with advanced solid tumors. The study includes a dose escalation stage, a dose expansion stage, and a indication expansion stage.
started
Jun 1, 2026
primary completion
Dec 1, 2028
completion
May 1, 2029
last updated
Apr 22, 2026
official title
A Phase I/II Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of SKB565 for Injection in Participants With Advanced Solid Tumors
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol